Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio, IDT Form RNA Sequencing Partnership

NEW YORK (GenomeWeb) – Takara Bio USA and Integrated DNA Technologies announced today that they have formed a collaboration to develop new RNA sequencing products. 

The companies will combine IDT's oligonucleotide manufacturing expertise with Takara's next-generation sequencing technologies to create probes and kits for low-input, targeted RNA-seq applications.

Additional terms of the arrangement were not disclosed.

"We believe that RNA-seq holds great promise for medical research and diagnostics, as well as for identification of novel therapeutic targets," Lorna Neilson, director of corporate development at Takara, said in a statement.

Takara Bio USA, formerly Clontech Laboratories, is a subsidiary of Japan's Takara Bio.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more